Swiss data analytics company SOPHiA Genetics SAis integrating a new radiomics technology to enhance its artificial intelligence (AI) platform, used already for analyzing genomic data from liquid biopsy tests in oncology. The radiomics capabilities were developed through a 10-year research project into mechanistic and mathematical modelling led by mathematics professor Thierry Colin at the INP research center in Bordeaux, France.
"The idea is to use radiology images with machine-learning techniques to predict the evolution of cancer tumors," Tarik Dlala, SOPHiA...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?